Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Patients in the CVC group were older and had lower albumin, BUN, and serum P levels as well as higher NT-proBNP (P < 0.05).Baseline characteristics of the CVC group and non-CVC groupCharacteristicCVC(n = 74)Non-CVC(n = 150) P Male [n(%)]42(56.8)106(70.7) < 0.05Age(year)68.9 ± 9.951.8 ± 13.9 < 0.05Dialysis duration (m,\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\overline{\mathrm{x} }$$\end{document}x¯±s)*21.9 ± 8.317.4 ± 7.7 < 0.05BMI(kg/m2,‾x ± s)22.93 ± 3.1523.22 ± 3.450.549CVD [n(%)]20(27.0)24(16.0)0.051DM [n(%)]18(24.3)37(24.7)0.955HBP [n(%)]71(95.9)147(98.0)0.399Smoking [n(%)]4(5.4)23(15.3) < 0.05RBC(× 10^12/L,‾x ± s)3.70 ± 0.633.74 ± 0.540.573Hb (g/L,‾x ± s)109.7 ± 15.5111.6 ± 15.30.407Plt (× 10^9/ L,‾x ± s)192.9 ± 54.1199.1 ± 54.50.426albumin(g/L,‾x ± s)36.4 ± 3.738.70 ± 3.2 < 0.05BUN (mmol/L,‾x ± s)22.5 ± 6.025.3 ± 6.0 < 0.05SCr (μmol/L,‾x ± s)896.9 + 216.61089.7 ± 268.1 < 0.05Ca (mmol/ L,‾x ± s)2.26 ± 0.282.32 ± 0.250.105P (mmol/L,‾x ± s)1.88 ± 0.622.11 ± 0.66 < 0.05iPTH(pg/ml,‾x ± s)379.7 ± 319.2365.0 ± 268.60.72325(OH)D(nmol/L)30.2(21.2 ~ 44.1)26.3(18.8 ~ 39.1)0.118TC(mmol/L,‾x ± s)4.19 ± 0.894.23 ± 1.000.880HDL-C (mmol/L,‾x ± s)1.05 ± 0.401.06 ± 0.340.961LDL-C (mmol/L,‾x ± s)2.51 ± 0.762.46 ± 0.870.827NT-proBNP(pg/ml)4854(2163 ~ 10,345)3065(1568 ~ 6009) < 0.05hsCRP(mg/L,‾x ± s)6.39 ± 10.106.50 ± 9.230.936Primary renal disease [n(%)] CG21(28.4%)69(46.0%) < 0.05 DN12(16.2%)26(17.3%)0.834 HN7(9.5%)5(3.3%)0.055 PKD7(9.5%)10(6.7%)0.458 Other23(31.1%)40(26.7%)0.131 BMI Body mass index, CVD Cardiovascular disease, DM Diabetes mellitus, RBC Red blood cells, Hb Haemoglobin, Plt Platelets, BUN Blood urea nitrogen, iPTH Intact parathyroid hormone, 25(OH)D 25-hydroxy vitamin D, TC Total cholesterol, HDL High-density lipoprotein cholesterol, LDL Low-density lipoprotein cholesterol, NT-proBNP N-terminal brain natriuretic peptide, CRP High-sensitivity C-reactive protein, CG Chronic glomerulonephritis, DN Diabetic nephropathy, HN Hypertensive nephropathy, PKD Polycystic kidney disease, Other Lupus nephritis, gouty nephropathy, nephrotuberculosis, chronic interstitial nephritis, lipoprotein glomerulopathy and so on

Source: Baseline characteristics of the cohort. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The patients were followed for a median of 4 years for all-cause mortality and cardiovascular mortality.

Source: Abstract.

This prospective cohort study recruited 224 patients who began HD therapy at the Blood Purification Center, Zhongshan Hospital, Fudan University, from January 1, 2010 to October 31, 2012.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Predictive role of cardiac valvular calcification in all-cause mortality of Chinese initial haemodialysis patients: a follow-up study of 4 years

Cohort study · BMC Nephrology · 2023

Original publication title

Predictive role of cardiac valvular calcification in all-cause mortality of Chinese initial haemodialysis patients: a follow-up study of 4 years

Yun Cheng; Zhihui Lu; Xuesen Cao; Xiaoqiang Ding; Jianzhou Zou; Huimin Jin

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

CVC at baseline is an independent risk factor for all-cause mortality in HD patients and makes an independent contribution to the prediction of all-cause mortality. These findings support the use of echocardiography at the beginning of HD.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Cardiac valvular calcification (CVC) is prevalent in haemodialysis (HD) patients. Its association with mortality in Chinese incident haemodialysis (IHD) patients remains unknown.

Source: Background

Abstract: What methods does the paper describe?

A total of 224 IHD patients who had just begun HD therapy at Zhongshan Hospital, Fudan University, were enrolled and divided into two groups according to the detection of cardiac valvular calcification (CVC) by echocardiography. The patients were followed for a median of 4 years for all-cause mortality and cardiovascular mortality.

Source: Methods

Abstract: Results

During follow-up, 56 (25.0%) patients died, including 29 (51.8%) of cardiovascular disease. The adjusted HR related to all-cause mortality was 2.14 (95% CI, 1.05 to 4.39) for patients with cardiac valvular calcification. However, CVC was not an independent risk factor for cardiovascular mortality in patients who had just begun HD therapy.

Source: Results

Abstract: Conclusion

CVC at baseline is an independent risk factor for all-cause mortality in HD patients and makes an independent contribution to the prediction of all-cause mortality. These findings support the use of echocardiography at the beginning of HD.

Source: Conclusion
Authors’ abstract

Background

Cardiac valvular calcification (CVC) is prevalent in haemodialysis (HD) patients. Its association with mortality in Chinese incident haemodialysis (IHD) patients remains unknown.

Methods

A total of 224 IHD patients who had just begun HD therapy at Zhongshan Hospital, Fudan University, were enrolled and divided into two groups according to the detection of cardiac valvular calcification (CVC) by echocardiography. The patients were followed for a median of 4 years for all-cause mortality and cardiovascular mortality.

Results

During follow-up, 56 (25.0%) patients died, including 29 (51.8%) of cardiovascular disease. The adjusted HR related to all-cause mortality was 2.14 (95% CI, 1.05 to 4.39) for patients with cardiac valvular calcification. However, CVC was not an independent risk factor for cardiovascular mortality in patients who had just begun HD therapy.

Conclusion

CVC at baseline is an independent risk factor for all-cause mortality in HD patients and makes an independent contribution to the prediction of all-cause mortality. These findings support the use of echocardiography at the beginning of HD.

Publication and source details

Original title: Predictive role of cardiac valvular calcification in all-cause mortality of Chinese initial haemodialysis patients: a follow-up study of 4 years

Yun Cheng; Zhihui Lu; Xuesen Cao; Xiaoqiang Ding; Jianzhou Zou; Huimin Jin

BMC Nephrology · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Project of Key Medical Discipline of Pudong Hospital of Fudan UniversityZdxk2020 -10Zdxk2020 -10Cheng Yun Jin Huimin

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T20:32:58.789893+00:00

DOI: 10.1186/s12882-023-03076-7 · PMC9933363